Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma
Characterizing the invasive tumor front of aggressive uterine adenocarcinoma and leiomyosarcoma Sabina Sanegre1, Núria Eritja2, 3, 4, 5, 6, Carlos de Andrea2, 7, Juan Díaz-Martín2, 8, 9, 10, 11, Ángel Díaz-Lagares2, 12, 13, María Amalia Jácome14, Carmen Salguero-Aranda8, 9, 10, 11, David García-Ros7, Ben Davidson15, 16, 17, Rafael López2, 13, 12, Ignacio Melero2, 18, Samuel Navarro2, 1, Santiago Ramon Y Cajal2, 19, Enrique De Álava2, 8, 9, 10, 11, Xavier Matias-Guiu2, 3, 5, 6, 4*, Rosa Noguera2, 20, 1* 1Institute of Health Research (INCLIVA), Spain, 2Centro de Investigaciónació Biomédica en Red del Cáncer (CIBERONC), Spain, 3Department of Pathology, University Hospital ArnauAr de Vilanova, Spain, 4Bellvitge University Hospital, Spain, 5Universitatt de Lleida, Spain, 6Universityniversity of Barcelona, Spain, 7University Clinic of Navarra, Spain, 8Institutetute of Biomedicine of Seville (IBIS), Spain,Sp 9Virgen del Rocío University Hospital, Spain, 10Consejo Superior de Investigaciones CientífiCientíficas (CSIC), Spain, 11Sevilla University, 12 13 Spain, University Clinical Hospital of Santiago, Spain,Spa Health Research Institute of Santiago de Compostelapostela (IDIS), Spain, 14Facultyculty of Science,Scie University of A Coruña, Spain, 15Institute of Clinical Medicine,ne, Faculty of Medicine,Me University of Oslo, Norway, 16Department of Pathology, Oslo University Hospital,l, Norway,Nor 17Norwegian Radium Hospital, Oslo University Hospital, Norway, 18Departamento de Dermatología,D Clínica Universidad de Navarra, Spain, 19Department of
[Show full text]